Olmesartan dosage guidelines
Pro Research Analysisby 
Searched over 200M research papers
Olmesartan Dosage Guidelines for Hypertension
Recommended Starting Dosage and Titration
For adult patients with hypertension, the typical starting dose of olmesartan medoxomil is 20 mg taken once daily. If blood pressure is not adequately controlled, the dose can be increased to a maximum of 40 mg once daily, as this range has been shown to be both effective and well-tolerated in clinical studies 235. Dose adjustments are usually made after 2 to 4 weeks, depending on the patient’s response 14.
Combination Therapy Dosage
When olmesartan is used in combination with hydrochlorothiazide (HCTZ), the recommended starting dose for patients not controlled on olmesartan alone is 40/12.5 mg (olmesartan/HCTZ), and for those not controlled on HCTZ alone, the starting dose is 20/12.5 mg. The dose can be adjusted as needed after 2 to 4 weeks, up to a maximum of 40 mg olmesartan and 25 mg HCTZ per day 14.
For patients requiring additional blood pressure control, fixed-dose combinations with amlodipine are also used. In one study, most patients achieved target blood pressure with a daily dose of 40/10 mg (olmesartan/amlodipine), while a smaller proportion responded to 40/5 mg .
Efficacy and Safety at Different Dosages
Clinical trials have shown that olmesartan at doses of 20–40 mg daily provides significant and sustained reductions in both systolic and diastolic blood pressure, with a good safety profile and low incidence of adverse effects 235. Higher doses, such as 40 mg, may offer additional benefits in arterial destiffening and remodeling, especially in patients with metabolic syndrome, compared to the 20 mg dose .
Special Considerations
- Dose adjustments should be made based on blood pressure response and tolerability.
- Olmesartan is effective as monotherapy or in combination with other antihypertensive agents, including HCTZ and amlodipine, especially in patients with more difficult-to-control hypertension or comorbidities like abdominal obesity 28.
- The safety profile of olmesartan is similar to placebo, and adverse events are not dose-dependent .
Conclusion
Olmesartan is typically started at 20 mg once daily for hypertension, with the option to increase to 40 mg if needed. For patients not controlled on monotherapy, fixed-dose combinations with HCTZ or amlodipine are effective, with dose adjustments made every 2 to 4 weeks. The drug is well-tolerated across recommended dosages and provides sustained blood pressure control.
Sources and full results
Most relevant research papers on this topic